| pubmed-article:19273714 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19273714 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19273714 | lifeskim:mentions | umls-concept:C0278488 | lld:lifeskim |
| pubmed-article:19273714 | lifeskim:mentions | umls-concept:C0246415 | lld:lifeskim |
| pubmed-article:19273714 | lifeskim:mentions | umls-concept:C0671970 | lld:lifeskim |
| pubmed-article:19273714 | lifeskim:mentions | umls-concept:C0045093 | lld:lifeskim |
| pubmed-article:19273714 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:19273714 | lifeskim:mentions | umls-concept:C0282461 | lld:lifeskim |
| pubmed-article:19273714 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:19273714 | pubmed:dateCreated | 2009-4-10 | lld:pubmed |
| pubmed-article:19273714 | pubmed:abstractText | Patients with metastatic breast cancer who are pretreated with anthracyclines frequently receive taxane-based combinations. This phase III study compared the efficacy and safety of gemcitabine-docetaxel (GD) with capecitabine-docetaxel (CD) in advanced breast cancer. | lld:pubmed |
| pubmed-article:19273714 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19273714 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19273714 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19273714 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19273714 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19273714 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19273714 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19273714 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19273714 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19273714 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19273714 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19273714 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19273714 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:19273714 | pubmed:issn | 1527-7755 | lld:pubmed |
| pubmed-article:19273714 | pubmed:author | pubmed-author:SchneeweissAn... | lld:pubmed |
| pubmed-article:19273714 | pubmed:author | pubmed-author:JonesAlisonA | lld:pubmed |
| pubmed-article:19273714 | pubmed:author | pubmed-author:LluchAnaA | lld:pubmed |
| pubmed-article:19273714 | pubmed:author | pubmed-author:RomieuGillesG | lld:pubmed |
| pubmed-article:19273714 | pubmed:author | pubmed-author:KreienbergRol... | lld:pubmed |
| pubmed-article:19273714 | pubmed:author | pubmed-author:FumoleauPierr... | lld:pubmed |
| pubmed-article:19273714 | pubmed:author | pubmed-author:ChanStephenS | lld:pubmed |
| pubmed-article:19273714 | pubmed:author | pubmed-author:HarrisonMarkM | lld:pubmed |
| pubmed-article:19273714 | pubmed:author | pubmed-author:AntónAntonioA | lld:pubmed |
| pubmed-article:19273714 | pubmed:author | pubmed-author:du... | lld:pubmed |
| pubmed-article:19273714 | pubmed:author | pubmed-author:HuoberJensJ | lld:pubmed |
| pubmed-article:19273714 | pubmed:author | pubmed-author:DelozierThier... | lld:pubmed |
| pubmed-article:19273714 | pubmed:author | pubmed-author:LlombartAnton... | lld:pubmed |
| pubmed-article:19273714 | pubmed:author | pubmed-author:CarrascoEvaE | lld:pubmed |
| pubmed-article:19273714 | pubmed:author | pubmed-author:Tubiana-Hulin... | lld:pubmed |
| pubmed-article:19273714 | pubmed:author | pubmed-author:MayordomoJose... | lld:pubmed |
| pubmed-article:19273714 | pubmed:author | pubmed-author:VauryA... | lld:pubmed |
| pubmed-article:19273714 | pubmed:author | pubmed-author:Frimodt-Molle... | lld:pubmed |
| pubmed-article:19273714 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19273714 | pubmed:day | 10 | lld:pubmed |
| pubmed-article:19273714 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:19273714 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19273714 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19273714 | pubmed:pagination | 1753-60 | lld:pubmed |
| pubmed-article:19273714 | pubmed:dateRevised | 2009-11-23 | lld:pubmed |
| pubmed-article:19273714 | pubmed:meshHeading | pubmed-meshheading:19273714... | lld:pubmed |
| pubmed-article:19273714 | pubmed:meshHeading | pubmed-meshheading:19273714... | lld:pubmed |
| pubmed-article:19273714 | pubmed:meshHeading | pubmed-meshheading:19273714... | lld:pubmed |
| pubmed-article:19273714 | pubmed:meshHeading | pubmed-meshheading:19273714... | lld:pubmed |
| pubmed-article:19273714 | pubmed:meshHeading | pubmed-meshheading:19273714... | lld:pubmed |
| pubmed-article:19273714 | pubmed:meshHeading | pubmed-meshheading:19273714... | lld:pubmed |
| pubmed-article:19273714 | pubmed:meshHeading | pubmed-meshheading:19273714... | lld:pubmed |
| pubmed-article:19273714 | pubmed:meshHeading | pubmed-meshheading:19273714... | lld:pubmed |
| pubmed-article:19273714 | pubmed:meshHeading | pubmed-meshheading:19273714... | lld:pubmed |
| pubmed-article:19273714 | pubmed:meshHeading | pubmed-meshheading:19273714... | lld:pubmed |
| pubmed-article:19273714 | pubmed:meshHeading | pubmed-meshheading:19273714... | lld:pubmed |
| pubmed-article:19273714 | pubmed:meshHeading | pubmed-meshheading:19273714... | lld:pubmed |
| pubmed-article:19273714 | pubmed:meshHeading | pubmed-meshheading:19273714... | lld:pubmed |
| pubmed-article:19273714 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19273714 | pubmed:articleTitle | Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer. | lld:pubmed |
| pubmed-article:19273714 | pubmed:affiliation | Nottingham University Hospital, City Campus, Nottingham, UK. steve.chan@nuh.nhs.uk | lld:pubmed |
| pubmed-article:19273714 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19273714 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:19273714 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:19273714 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:19273714 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:19273714 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19273714 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19273714 | lld:pubmed |
